I call last run up almost to the day.
It's almost time again..
Expect a run next week (last week of September going
Into first week of October) as anticipation for FDA filing approaches
In the middle of October. We should see a decent pop on the actual file date too.
rNDA filing will be a non-event. It is a given, and therefore baked in, that it will occur mid October. Earnings CC will have more of an effect on PPS depending on whether losses are less or greater than analyst projections. IMO, there are only two catalysts remaining between now and April/2014. A partnership/buyout announcement and the FDA decision.